Capital Markets Day

RNS Number : 7461B
Cambridge Cognition Holdings PLC
11 June 2019
 

Cambridge Cognition Holdings Plc

('Cambridge Cognition' or the 'Company')

 

Capital Markets Day

 

The neuroscience technology company Cambridge Cognition Holdings plc (AIM: COG), which develops and markets neuroscience technologies to assess brain health, is pleased to announce that it will be hosting a Capital Markets Day on 13 June 2019 at 10am at the offices of finnCap, 60 New Broad Street, EC2M 1JJ.

 

The event will feature a series of presentations from Cambridge Cognition's management and senior leadership team focussing on the latest developments in the product and technology portfolios.

 

To register for the event please email IR@finncap.com 

 

No new material information or update on current trading will be disclosed at the event.

 

Enquiries

 

Cambridge Cognition Holdings PLC

Matthew Stork, Chief Executive Officer

Nick Walters, Chief Financial Officer

 

Tel: 01223 810 700

press@camcog.com

finnCap Ltd (NOMAD and Joint Broker)

Geoff Nash / Simon Hicks

Alice Lane / Manasa Patil

Tel: 020 7220 0500

(Corporate Finance)

(ECM)

Dowgate Capital Limited (Joint Broker)

David Poutney / James Serjeant

Tel: 020 3903 7715

 

IFC Advisory Ltd (Financial PR and IR)

Tim Metcalfe / Miles Nolan / Zach Cohen

Tel: 020 3934 6630

 


About Cambridge Cognition


Cambridge Cognition is a neuroscience technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early, and reduce global R&D and healthcare costs.

 

For further information visit www.cambridgecognition.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGGURWQUPBGBU
UK 100

Latest directors dealings